Quick Answer
SUTRO BIOPHARMA, INC. reported Total Assets of $173.83 million for fiscal year 2025.
SUTRO BIOPHARMA, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $173.83M | -55.1% |
| 2024 | $387.21M | -17.7% |
| 2023 | $470.74M | +15.7% |
| 2022 | $406.94M | +19.2% |
| 2021 | $341.41M | -13.4% |
| 2020 | $394.11M | +152.0% |
| 2019 | $156.37M | -29.9% |
| 2018 | $223.14M | +447.3% |
| 2017 | $40.77M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $209.66M | -53.6% | -20.1% |
| June 30, 2025 | $262.36M | -46.4% | -18.4% |
| March 31, 2025 | $321.43M | -20.3% | -17.0% |
| December 31, 2024 | $387.21M | -17.7% | -14.3% |
| September 30, 2024 | $451.83M | +4.7% | -7.6% |
| June 30, 2024 | $489.04M | +5.2% | +21.2% |
| March 31, 2024 | $403.40M | +12.7% | -14.3% |
| December 31, 2023 | $470.74M | +15.7% | +9.0% |
- SUTRO BIOPHARMA, INC. showed a decrease of -55.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, SUTRO BIOPHARMA, INC.’s total assets has grown by 326.4% (from $40.77 million to $173.83 million).
- The most recent figure is from SUTRO BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: